We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.96B
1-Year Est. Return 48.96%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+48.96%
3 Year Est. Return
+156.47%
5 Year Est. Return
+196.14%
10 Year Est. Return
+689.54%
AUM
$1.05B
AUM Growth
-$68.1M
Cap. Flow
-$92.6M
Cap. Flow %
-8.82%
Top 10 Hldgs %
22.12%
Holding
2,122
New
405
Increased
518
Reduced
436
Closed
484

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Financials 12.43%
3 Healthcare 9.96%
4 Industrials 9.86%
5 Consumer Discretionary 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNBC
1176
DELISTED
Sun Bancorp Inc
SNBC
$6K ﹤0.01%
238
-6
-2% -$150
AAT
1177
American Assets Trust
AAT
$1.4B
$5K ﹤0.01%
139
AKBA icon
1178
Akebia Therapeutics
AKBA
$252M
$5K ﹤0.01%
317
-357
-53% -$4.53K
APLE icon
1179
Apple Hospitality REIT
APLE
$3.82B
$5K ﹤0.01%
269
-1,575
-85% -$29.9K
BHB icon
1180
Bar Harbor Bankshares
BHB
$666M
$5K ﹤0.01%
178
+48
+37% +$1.45K
CIVI
1181
DELISTED
Civitas Resources
CIVI
$5K ﹤0.01%
+160
New +$8.75K
DGII icon
1182
Digi International
DGII
$3.1B
$5K ﹤0.01%
+447
New +$4.75K
DIOD icon
1183
Diodes
DIOD
$4.84B
$5K ﹤0.01%
212
+90
+74% +$2.22K
DVAX
1184
DELISTED
Dynavax Technologies
DVAX
$5K ﹤0.01%
531
-293
-36% -$1.9K
ELDN icon
1185
Eledon Pharmaceuticals
ELDN
$285M
$5K ﹤0.01%
50
+30
+150% +$3.06K
ESPR
1186
DELISTED
Esperion Therapeutics
ESPR
$5K ﹤0.01%
99
-15
-13% -$552
FUL icon
1187
H.B. Fuller
FUL
$3.28B
$5K ﹤0.01%
98
-42
-30% -$2.17K
TDAY
1188
USA Today Co
TDAY
$1.06B
$5K ﹤0.01%
348
CBIO
1189
Crescent Biopharma
CBIO
$626M
$5K ﹤0.01%
4
-3
-43% -$2.48K
LRMR icon
1190
Larimar Therapeutics
LRMR
$432M
$5K ﹤0.01%
127
+56
+79% +$2.86K
MGNI icon
1191
Magnite
MGNI
$3.55B
$5K ﹤0.01%
1,063
+56
+6% +$308
MITK icon
1192
Mitek Systems
MITK
$835M
$5K ﹤0.01%
647
+580
+866% +$4.73K
NHTC icon
1193
Natural Health Trends
NHTC
$14.8M
$5K ﹤0.01%
+174
New +$4.97K
NTLA icon
1194
Intellia Therapeutics
NTLA
$1.67B
$5K ﹤0.01%
318
-69
-18% -$964
NVAX icon
1195
Novavax
NVAX
$1.31B
$5K ﹤0.01%
224
NVRI icon
1196
Enviri
NVRI
$620M
$5K ﹤0.01%
+323
New +$4.66K
PAHC icon
1197
Phibro Animal Health
PAHC
$1.39B
$5K ﹤0.01%
126
-139
-52% -$4.54K
PETS icon
1198
PetMed Express
PETS
$42.3M
$5K ﹤0.01%
+125
New +$3.87K
QNST icon
1199
QuinStreet
QNST
$1.21B
$5K ﹤0.01%
1,176
REVG
1200
DELISTED
REV Group
REVG
$5K ﹤0.01%
+175
New +$4.88K

Similar funds

Meeder Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Meeder Asset Management held 2,122 positions worth $1.05B, down 6.1% from $1.12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Meeder Asset Management withdrew a net $92.6M in Q2 2017, closing 484 positions and reducing 436 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Meeder Asset Management opened a new position in Humana worth $5.43M.

  • Meeder Asset Management's largest Q2 2017 buy was Humana: 22,582 shares worth $5.43M.
  • Meeder Asset Management added most to State Street SPDR Bloomberg High Yield Bond ETF in Q2 2017, an estimated $23.9M increase.
  • Meeder Asset Management's biggest Q2 2017 reduction was iShares MSCI EAFE ETF, cutting an estimated $41.8M.
  • Meeder Asset Management fully exited iShares 20+ Year Treasury Bond ETF in Q2 2017, selling an estimated $13M.
  • Meeder Asset Management's ten largest holdings make up 22% of its $1.05B portfolio in Q2 2017.
  • Meeder Asset Management opened 405 new positions and closed 484 in Q2 2017.
  • Meeder Asset Management's portfolio value fell 6.1% quarter-over-quarter to $1.05B.

Based on Meeder Asset Management's 13F filing for Q2 2017, filed 13 Jul 2017.